Abstract:OBJECTIVE:To screen and identify peptides that binds specifically to gastric cancers cells with high metastasis to peritoneum so as to find appropriate vectors for targeting therapy for cancer.METHODS:Human gastric cancer cells of the line GC9811 and those with high metastasis to peritoneum of the line GC9811-P were co-incubated with the 12-mer bacteriophage random peptide library. After 3 round of repeated screening, phage clones were collected. Forty internalized phage single-stranded DNA that specifically binding to the GC98112-P cells were sequenced. GC9811 and GC9811-P cells were co-inoculated with 5 peptides with the N end marked with fluorescein isothiocyanate (FITC) and 1 un-related peptide not binding to GC9811 and GC9811-P cells. Fluorescence microscopy, ELISA, and flow cytometry were used to detect the binding activity. BALB/cnu/nu mice were inoculated intraperitoneally with GC9811 and GC9811-P cells and then randomly divided into. 2 equal groups: experimental group, inoculated with the peptide PIII-FITC and control group (inoculated with un-related peptide PC-FITC. Forty-eight hours later the mice were killed and the peritoneum and tumor masses in different organs were collected and under fluorescence microscopy.RESULTS:DNA sequencing showed that 45% (18/45) of the isolated phages displayed repeated sequence SMSIASPYIALE, and SMSI was defined as a conservative motif. Obvious fluorescence was seen in the GC9811-P cells co-incubated with PIII-FITC and weak fluorescence was seen in the GC9811 cells co-incubated with PIII-FITC. Un-marked un-related peptide PC and PIII-FITC did not influenced the fluorescence staining of the GC9811-P cells, however, no fluorescence could be seen in the GC9811-P cells co-incubated with un-marked PIII and PIII-FITC. The fluorescence positive cell rate was 5.9% in the GC9811 cells co-incubated with PIII-FITC, and was 90.2% in the GC9811-P cells co-incubated with PIII-FITC. The fluorescence positive cell rates of the GC9811 cells and GC9811-P cells co-incubated with PC-FITC were 10.1% and 9.9% respectively 10.1% and 9.9% respectively. The fluorescence strength of the GC9811-P cells co-incubated with PIII-FITC was significantly greater than that of the GC9811-P cells co-incubated with PC-FTIC at any time-point and dose (all P < 0.01), and increased along with the increase of co-incubation time and dose of PIII-FITC. The peritoneal tumor tissues caused by the GC9811-P cells of the mice showed strong fluorescence and those caused by GC9811 cells only showed very weak fluorescence. Weak fluorescence could be seen in the tumor masses in the lymph nodes, liver, and muscle of the mice inoculated with GC9811-P cells and was not seen in the tissues of the mice inoculated with GC9811 cells.CONCLUSION:The sequence SMSIASPYIALE that specifically binds to human gastric cancer cells with high metastasis has been screened that has the potential to be used as a marker and targeting vector in diagnosis and treatment of gastric cancer.

Screening and Identification of Phage-Displayed Polypeptides Specifically Binding to Human Gastric Cancer with High Metastatic Potential to Peritoneum

[Preliminary Screening and Identification of a Peptide That Binds Specifically to Gastric Cancers Cells with High Metastasis to Peritoneum].

Screening and Characterization of Multipeptide Binding Specifically to Gastric Cancer Cells by Phage Peptide Library

Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer

Phage Display Selection of Peptides That Inhibit Metastasis Ability of Gastric Cancer Cells with High Liver-Metastatic Potential.

Affinity Peptide Developed by Phage Display Selection for Targeting Gastric Cancer.

Selection and Characterization of a Peptide Specifically Targeting to Gastric Cancer Cell Line SGC-7901 Using Phage Display

Screening and Identification of Mimotope of Gastric Cancer Associated Antigen Mgb1-Ag

Characterization of a specific phage-displayed Peptide binding to vasculature of human gastric cancer.

Screening and Identification of Vascular-Endothelial-cell-specific Binding Peptide in Gastric Cancer

Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

[Screening of Bioactive Peptide That Mimic the Epitope of Gastric Cancer Associated Antigen].

The further characterization of the peptide specifically binding to gastric cancer

Ph.D. -C7CTM Phage Display Peptide Library Selection on Gastric Cancer MDR Cells to Yield Specific Binding Peptides

The selection and characterization of the peptides binding to the cells and tissues of gastric carcinoma

Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library

Screening and Identification of Polypeptides Specifically Binding to Hepatoma Carcinoma Cells

Identifying Peptides That Specifically Bind to MDA-MB-468 Breast Cancer Cells*

[Phage Display Random Peptide Library for Screening the Peptides That Specifically Bind to Hepatocellular Carcinoma Cells].

In Vivo Screening with Ph . D .7 TM and Identification of Ovarian Cancer A 2780 Cell Targeted